1. Home
  2. ABCL vs MTH Comparison

ABCL vs MTH Comparison

Compare ABCL & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$9.66

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Logo Meritage Homes Corporation

MTH

Meritage Homes Corporation

N/A

Current Price

$62.14

Market Cap

4.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
ABCL
MTH
Founded
2012
1985
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.4B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
ABCL
MTH
Price
$9.66
$62.14
Analyst Decision
Strong Buy
Hold
Analyst Count
14
10
Target Price
$18.69
★ $69.63
AVG Volume (30 Days)
★ 2.8M
911.4K
Earning Date
11-09-2026
10-28-2026
Dividend Yield
N/A
★ 3.13%
EPS Growth
★ 10.91
N/A
EPS
N/A
★ 3.22
Revenue
★ $75,128,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.74
$2.85
P/E Ratio
★ N/A
$19.04
Revenue Growth
★ 160.56
N/A
52 Week Low
$2.75
$56.66
52 Week High
$14.98
$85.38

Technical Indicators

Market Signals
Indicator
ABCL
MTH
Relative Strength Index (RSI) 34.01 44.39
Support Level $3.45 $57.94
Resistance Level $12.91 $76.89
Average True Range (ATR) 0.84 2.29
MACD -0.22 -0.77
Stochastic Oscillator 2.41 11.06

Price Performance

Historical Comparison
ABCL
MTH

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.

Share on Social Networks: